Elyssa Sliheet: Genetic Network Analysis

There exists the need to develop and study the effects of novel immunotherapies for the treatment of various cancer types. Unlike chemotherapy and radiotherapy which directly target the cite of a tumor, immunotherapies serve as catalysts to activate the body's immune response. Studies have shown the benefits of immunotherapies. However, there is still need to computationally analyze genetic data to identify relevant biomarkers as related to clinical significance for the overall advancement of targeted medicine. In this research, we construct and analyze important properties of a protein-protein interaction network. These properties shed light on potential biomarkers relevant to patient immune response and sensitivity.